{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-23",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 19
    }
  },
  "results": [
    {
      "update_type": "Revised",
      "initial_posting_date": "01/01/2012",
      "package_ndc": "16729-525-08",
      "generic_name": "Atropine Sulfate Injection",
      "contact_info": "866-941-7875, option 2",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: mid-September 2026",
      "update_date": "09/01/2026",
      "therapeutic_category": [
        "Anesthesia",
        "Neurology",
        "Pediatric"
      ],
      "dosage_form": "Injection",
      "presentation": "Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-525-08)",
      "company_name": "Accord Healthcare Inc.",
      "shortage_reason": "Requirements related to complying with good manufacturing practices",
      "status": "Current"
    }
  ]
}